(-)-Epigallocatechin-3-gallate inhibits entry of hepatitis B virus into hepatocytes

Antiviral Research

Volumn 111, Issue , 2014, Pages 100-111

  Huang, Hsiu Chen ^a   Tao, Mi Hua ^b   Hung, Tzu Min ^c   Chen, Jui Chieh ^d   Lin, Zi Jun ^e   Huang, Cheng ^e  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^c E DA HOSPITAL   (Taiwan)

^d NATIONAL CHIAYI UNIVERSITY   (Taiwan)

^e NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE   (Taiwan)

Author keywords

EGCG; Hepatitis B virus; Virus entry

Indexed keywords

CATECHIN; CHRYSIN; CLATHRIN; CURCUMIN; DIMETHYL SULFOXIDE; EPIGALLOCATECHIN GALLATE; GALLIC ACID; PARA COUMARIC ACID; PLANT MEDICINAL PRODUCT; QUERCETIN; ROTENONE; RUTOSIDE; SODIUM BILE ACID COTRANSPORTER; TRANSFERRIN; URSOLIC ACID; ANTIVIRUS AGENT; PLANT EXTRACT;

ANTIVIRAL ACTIVITY; ARTICLE; CELL IMMORTALIZATION; CELL MEMBRANE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG IDENTIFICATION; ENDOCYTOSIS; GENE REPLICATION; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; INOCULATION; LIVER CELL; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; VIRION; VIRUS ENTRY; VIRUS GENOME; VIRUS INHIBITION; ANALOGS AND DERIVATIVES; CELL LINE; DRUG EFFECTS; GENETICS; PHYSIOLOGY; VIROLOGY; VIRUS REPLICATION;

HEPATITIS B VIRUS;

ANTIVIRAL AGENTS; CATECHIN; CELL LINE; HEPATITIS B; HEPATITIS B VIRUS; HEPATOCYTES; HUMANS; PLANT EXTRACTS; VIRUS INTERNALIZATION; VIRUS REPLICATION;

EID: 84907985176     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2014.09.009     Document Type: Article

References (41)

1. H.H. Aly, K. Watashi, M. Hijikata, H. Kaneko, Y. Takada, H. Egawa, S. Uemoto, and K. Shimotohno Serum-derived hepatitis C virus infectivity in interferon regulatory factor-7-suppressed human primary hepatocytes J. Hepatol. 46 2007 26 36
2. A. Banerjee, and P.W. Swaan Membrane topology of human ASBT (SLC10A2) determined by dual label epitope insertion scanning mutagenesis. New evidence for seven transmembrane domains Biochemistry 45 2006 943 953
3. R.P. Beasley Hepatitis B virus. The major etiology of hepatocellular carcinoma Cancer 61 1988 1942 1956
4. N. Calland, A. Albecka, S. Belouzard, C. Wychowski, G. Duverlie, V. Descamps, D. Hober, J. Dubuisson, Y. Rouille, and K. Seron (-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry Hepatology 55 2011 720 729
5. J. Campsen, M. Zimmerman, J. Trotter, J. Hong, C. Freise, R.S. Brown Jr., J. Campsen, M. Zimmerman, J. Trotter, J. Hong, C. Freise, R.S. Brown Jr., A. Cameron, M. Ghobrial, I. Kam, R. Busuttil, S. Saab, C. Holt, J.C. Emond, J.B. Stiles, T. Lukose, M.S. Chang, and G. Klintmalm Multicenter review of liver transplant for hepatitis B-related liver disease: disparities in gender and ethnicity Clin. Transplant. 27 2013 829 837
6. C.C. Chen, T.M. Ko, H.I. Ma, H.L. Wu, X. Xiao, J. Li, C.M. Chang, P.Y. Wu, C.H. Chen, J.M. Han, C.P. Yu, K.S. Jeng, C.P. Hu, and M.H. Tao Long-term inhibition of hepatitis B virus in transgenic mice by double-stranded adeno-associated virus 8-delivered short hairpin RNA Gene Ther. 14 2007 11 19
7. S.H. Chen Comparative evaluation of L-Fd4C and related nucleoside analogs as promising antiviral agents Curr. Med. Chem. 9 2002 899 912
8. H.H. Chow, Y. Cai, I.A. Hakim, J.A. Crowell, F. Shahi, C.A. Brooks, R.T. Dorr, Y. Hara, and D.S. Alberts Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals Clin. Cancer Res. 9 2003 3312 3319
9. F. Galibert, E. Mandart, F. Fitoussi, P. Tiollais, and P. Charnay Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli Nature 281 1979 646 650
10. D. Ganem, and A.M. Prince Hepatitis B virus infection - natural history and clinical consequences N. Engl. J. Med. 350 2004 1118 1129
11. C.A. Geng, L.J. Wang, R.H. Guo, and J.J. Chen Small-molecule inhibitors for the treatment of hepatitis B virus documented in patents Mini Rev. Med. Chem. 13 2013 749 776
12. R. Gonzalez, A. Cruz, G. Ferrin, P. Lopez-Cillero, J. Briceno, M.A. Gomez, S. Rufian, J. Padillo, M. De la Mata, J.J. Marin, and J. Muntane Cytoprotective properties of rifampicin are related to the regulation of detoxification system and bile acid transporter expression during hepatocellular injury induced by hydrophobic bile acids J. Hepatobiliary Pancreat. Sci. 18 2011 740 750
13. P. Gripon, S. Rumin, S. Urban, J. Le Seyec, D. Glaise, I. Cannie, C. Guyomard, J. Lucas, C. Trepo, and C. Guguen-Guillouzo Infection of a human hepatoma cell line by hepatitis B virus Proc. Natl. Acad. Sci. U.S.A. 99 2002 15655 15660
14. B. Hagenbuch, B. Stieger, M. Foguet, H. Lubbert, and P.J. Meier Functional expression cloning and characterization of the hepatocyte Na+/bile acid cotransport system Proc. Natl. Acad. Sci. U.S.A. 88 1991 10629 10633
15. C. Hartmann-Stuhler, and R. Prange Hepatitis B virus large envelope protein interacts with gamma2-adaptin, a clathrin adaptor-related protein J. Virol. 75 2001 5343 5351
16. H.C. Huang, C.C. Chen, W.C. Chang, M.H. Tao, and C. Huang Entry of hepatitis B virus into immortalized human primary hepatocytes by clathrin-dependent endocytosis J. Virol. 86 2012 9443 9453
17. C.E. Isaacs, G.Y. Wen, W. Xu, J.H. Jia, L. Rohan, C. Corbo, V. Di Maggio, E.C. Jenkins Jr., and S. Hillier Epigallocatechin gallate inactivates clinical isolates of herpes simplex virus Antimicrob. Agents Chemother. 52 2008 962 970
18. J.H. Kao, P.J. Chen, M.Y. Lai, and D.S. Chen Hepatitis B virus genotypes and spontaneous hepatitis B e antigen seroconversion in Taiwanese hepatitis B carriers J. Med. Virol. 72 2004 363 369
19. K. Kawai, N.H. Tsuno, J. Kitayama, Y. Okaji, K. Yazawa, M. Asakage, N. Hori, T. Watanabe, K. Takahashi, and H. Nagawa Epigallocatechin gallate, the main component of tea polyphenol, binds to CD4 and interferes with gp120 binding J. Allergy Clin. Immunol. 112 2003 951 957
20. M. Kim, S.Y. Kim, H.W. Lee, J.S. Shin, P. Kim, Y.S. Jung, H.S. Jeong, J.K. Hyun, and C.K. Lee Inhibition of influenza virus internalization by (-)-epigallocatechin-3-gallate Antiviral Res. 100 2013 460 472
21. G.J. Kotwal Genetic diversity-independent neutralization of pandemic viruses (e.g. HIV), potentially pandemic (e.g. H5N1 strain of influenza) and carcinogenic (e.g. HBV and HCV) viruses and possible agents of bioterrorism (variola) by enveloped virus neutralizing compounds (EVNCs) Vaccine 26 2008 3055 3058
22. G.A. Kullak-Ublick, J. Glasa, C. Boker, M. Oswald, U. Grutzner, B. Hagenbuch, B. Stieger, P.J. Meier, U. Beuers, W. Kramer, G. Wess, and G. Paumgartner Chlorambucil-taurocholate is transported by bile acid carriers expressed in human hepatocellular carcinomas Gastroenterology 113 1997 1295 1305
23. H.C. Lin, Y.F. Chen, W.H. Hsu, C.W. Yang, C.H. Kao, and T.F. Tsai Resveratrol helps recovery from fatty liver and protects against hepatocellular carcinoma induced by hepatitis B virus X protein in a mouse model Cancer Prev. Res. (Phila) 5 2012 952 962
24. M. Lutgehetmann, L.V. Mancke, T. Volz, M. Helbig, L. Allweiss, T. Bornscheuer, J.M. Pollok, A.W. Lohse, J. Petersen, S. Urban, and M. Dandri Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation Hepatology 55 2011 685 694
25. I. Mellman Endocytosis and molecular sorting Annu. Rev. Cell Dev. Biol. 12 1996 575 625
26. C.H. Miao, K. Ohashi, G.A. Patijn, L. Meuse, X. Ye, A.R. Thompson, and M.A. Kay Inclusion of the hepatic locus control region, an intron, and untranslated region increases and stabilizes hepatic factor IX gene expression in vivo but not in vitro Mol. Ther. 1 2000 522 532
27. Y. Ni, F.A. Lempp, S. Mehrle, S. Nkongolo, C. Kaufman, M. Falth, J. Stindt, C. Koniger, M. Nassal, R. Kubitz, H. Sultmann, and S. Urban Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes Gastroenterology 146 2013 1070 1083
28. S. Pei, Y. Zhang, H. Xu, X. Chen, and S. Chen Inhibition of the replication of hepatitis B virus in vitro by pu-erh tea extracts J. Agric. Food Chem. 59 2011 9927 9934
29. J. Petersen, M. Dandri, W. Mier, M. Lutgehetmann, T. Volz, F. von Weizsacker, U. Haberkorn, L. Fischer, J.M. Pollok, B. Erbes, S. Seitz, and S. Urban Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein Nat. Biotechnol. 26 2008 335 341
30. M. Renouf, K. Redeuil, K. Longet, C. Marmet, F. Dionisi, M. Kussmann, G. Williamson, and K. Nagy Plasma pharmacokinetics of catechin metabolite 4′-O-Me-EGC in healthy humans Eur. J. Nutr. 50 2011 575 580
31. S.L. Schmid Clathrin-coated vesicle formation and protein sorting: an integrated process Annu. Rev. Biochem. 66 1997 511 548
32. M.A. Sells, M.L. Chen, and G. Acs Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA Proc. Natl. Acad. Sci. U.S.A. 84 1987 1005 1009
33. J.M. Song, K.H. Lee, and B.L. Seong Antiviral effect of catechins in green tea on influenza virus Antiviral Res. 68 2005 66 74
34. C. Stross, S. Kluge, K. Weissenberger, E. Winands, D. Haussinger, and R. Kubitz A dileucine motif is involved in plasma membrane expression and endocytosis of rat sodium taurocholate cotransporting polypeptide (Ntcp) Am. J. Physiol. Gastrointest. Liver Physiol. 305 2013 G722 G730
35. Y. Tamba, S. Ohba, M. Kubota, H. Yoshioka, and M. Yamazaki Single GUV method reveals interaction of tea catechin (-)-epigallocatechin gallate with lipid membranes Biophys. J. 92 2007 3178 3194
36. Q.C. Toh, T.L. Tan, W.Q. Teo, C.Y. Ho, S. Parida, and W.N. Chen Identification of cellular membrane proteins interacting with hepatitis B surface antigen using yeast split-ubiquitin system Int. J. Med. Sci. 2 2005 114 117
37. G.F. Wang, L.P. Shi, Y.D. Ren, Q.F. Liu, H.F. Liu, R.J. Zhang, Z. Li, F.H. Zhu, P.L. He, W. Tang, P.Z. Tao, C. Li, W.M. Zhao, and J.P. Zuo Anti-hepatitis B virus activity of chlorogenic acid, quinic acid and caffeic acid in vivo and in vitro Antiviral Res. 83 2009 186 190
38. J.S. Wang, H. Luo, P. Wang, L. Tang, J. Yu, T. Huang, S. Cox, and W. Gao Validation of green tea polyphenol biomarkers in a phase II human intervention trial Food Chem. Toxicol. 46 2008 232 240
39. K. Watashi, S. Urban, W. Li, and T. Wakita NTCP and beyond: opening the door to unveil hepatitis B virus entry Int. J. Mol. Sci. 15 2014 2892 2905
40. H. Yan, G. Zhong, G. Xu, W. He, Z. Jing, Z. Gao, Y. Huang, Y. Qi, B. Peng, H. Wang, L. Fu, M. Song, P. Chen, W. Gao, B. Ren, Y. Sun, T. Cai, X. Feng, J. Sui, and W. Li Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus Elife 1 2012 e00049
41. F. Zoulim, and S. Locarnini Hepatitis B virus resistance to nucleos(t)ide analogues Gastroenterology 137 1593-1608 2009 e1591 e1592